Q3 2021 Holdings
Filed 2021-11-15 | 120 holdings | $949.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $317.8M | 1,683,362 | 33.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $211.0M | 3,908,947 | 22.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $111.5M | 2,494,965 | 11.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $71.5M | 2,000,000 | 7.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $53.3M | 1,616,497 | 5.6% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $47.1M | 3,398,279 | 5.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $42.4M | 140,311 | 4.5% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $39.8M | 599,009 | 4.2% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $20.3M | 4,733,323 | 2.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $9.9M | 830,794 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.1M | 1,400,939 | 0.8% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $5.0M | 280,000 | 0.5% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $4.3M | 491,834 | 0.5% |
| Cvrx Inc(CVRX) | COM | 126638105 | $2.5M | 150,000 | 0.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $469.6K | 15,802,802 | 0.0% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $374.7K | 873,255 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $264.0K | 1,492,532 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $237.7K | 416,000 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $225.4K | 832,540 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $220.5K | 4,517,570 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $207.5K | 1,862,234 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $197.0K | 5,293,966 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $195.8K | 482,791 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $166.0K | 2,319,138 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $152.9K | 7,582,396 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $138.6K | 1,160,734 | 0.0% |
| Globus MED Inc(GMED) | CL A | 379577208 | $128.0K | 1,670,811 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $126.5K | 1,943,864 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $118.1K | 4,795,000 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $115.7K | 925,342 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $109.2K | 6,722,624 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $108.8K | 3,855,291 | 0.0% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $106.9K | 734,481 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $102.7K | 385,194 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $100.1K | 3,118,665 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $92.7K | 3,644,248 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $83.3K | 3,266,255 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $83.2K | 3,975,554 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $77.4K | 3,264,031 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $77.4K | 1,845,366 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $63.5K | 2,353,015 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $62.4K | 4,275,722 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $58.6K | 1,257,862 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $56.3K | 5,741,939 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $53.9K | 6,443,113 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $48.6K | 2,458,750 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $47.6K | 9,074,438 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $46.2K | 1,245,532 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $45.7K | 2,168,957 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $44.2K | 894,652 | 0.0% |